8K May 2004
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
---------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) of the SECURITIES EXCHANGE ACT OF 1934
Date of earliest event reported: May 17, 2004
WEST PHARMACEUTICAL SERVICES, INC.
(Exact name of registrant as specified in charter)
Pennsylvania 1-8036 23-1210010
(State of Incorporation) (Commission File Number) (I.R.S. Employer
Identification No.)
101 Gordon Drive, P.O. Box 645, Lionville, Pennsylvania 19341-0645
(Address of Principal Executive Offices) (Zip Code)
(610) 594-2900
(Registrant's telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
--------------------------------------------------------------------------------
Item 5. Other Events and Regulation FD Disclosure.
On May 17, 2004 West Pharmaceutical Services, Inc. (the "Company")
entered into a $125 million dollar revolving credit facility with
a consortium of banks. A copy of the Credit Agreement is attached
hereto as Exhibit 99.1. A copy of the press release announcing
the financing is attached hereto as Exhibit 99.2 and is
incorporated herein by reference.
Item 7. Financial Statements and Exhibits.
(c) Exhibits: Exhibit List Index on page 4 of this report
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
WEST PHARMACEUTICAL SERVICES, INC.
Date: May 28, 2004 By: /s/J.R.Gailey
-------------------------------
Name: John R. Gailey III
title: Vice President